CDHA CAAR

October 22, 2021

CAAR – Lancet Neurology Article – October 22, 2021

Filed under: Reports and Articles — admin @ 6:04 pm

Note: Check with your organization’s library for availability. “Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer’s disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial,” by Patrick Gavin Kehoe, Nicholas Turner, Beth Howden, Lina Jarutyte, Shona Louise Clegg, Ian Brian Malone, Josephine Barnes, Casper Nielsen, Carole Hélène Sudre, Aileen Wilson, Ngoc Jade Thai, Peter Sinclair Blair, Elizabeth Coulthard, Janet Athene Lane, Peter Passmore, Jodi Taylor, Henk-Jan Mutsaerts, David Lee Thomas, Nick Charles Fox, Ian Wilkinson, and Yoav Ben-Shlomoon behalf of the RADAR investigators (Vol. 20, No. 11, November 2021, .pdf and HTML format, p. 895-906).

www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00263-5/fulltext

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress